Picture of Vericel logo

VCEL Vericel Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Annual cashflow statement for Vericel, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-9.662.86-7.47-16.7-3.18
Depreciation
Non-Cash Items15.418.739.741.637.8
Unusual Items
Other Non-Cash Items
Changes in Working Capital-14.7-6.37-6.15-11.2-3.96
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Net Change in Other Assets & Liabilities
Cash from Operating Activities-7.1817.62917.735.3
Capital Expenditures-2.62-2.63-7.92-7.6-27.5
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items13.2-14.54.41-28.624.4
Change in Net Investments
Purchase of Investments
Cash from Investing Activities10.6-17.2-3.5-36.2-3.13
Financing Cash Flow Items-0.026-0.191-2.01-2.61-2.38
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities5.266.449.171.043.62
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash8.696.8534.7-17.535.8